4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-015921
CEO and CFO bought 9,250 shares at $8.35 ($77,238)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-06-03 | Purchase | +9,250 | $8.35 | $77,238 | 1,232,953 | D |
| Open-market purchases · 9,250 sh · avg $8.35 · $77,238 | |||||||
Loading xslF345X03/ownership.xml…